Fuxin Pharma (01652.HK): "Nifedipine Hydrochloride Injection" consistency evaluation application approved for listing.

World Financial News APP news, Fosen Pharmaceuticals (01652.HK) announced that the "Nicardipine Hydrochloride Injection" developed by its wholly-owned subsidiary Henan Fosen Pharmaceuticals Co., Ltd. has obtained approval from the China National Medical Products Administration for its consistency evaluation application, approved for emergency management of abnormally high blood pressure during surgery, and hypertensive emergencies.